Important Medication Advisory
IMPORTANT MEDICATION ADVISORY: Limbrel (Primus Pharmaceuticals)
Limbrel is a nutritional medicine in capsule form marketed to manage “the metabolic processes associated with osteoarthritis.” It has come to our attention that the FDA has recommended that Primus Pharmaceuticals, the manufacturer of Limbrel, voluntarily recall the drug from the marketplace due to a serious risk of adverse health effects in patients. In an updated statement on 12/5/17, the FDA reminds consumers that Limbrel has the risk of drug-induced liver injury, as well as a lung condition called hypersensitivity pneumonitis.
IF YOU ARE TAKING LIMBREL, WE ADVISE THAT YOU STOP TAKING THIS MEDICATION IMMEDIATELY. IN ADDITION TO IMMEDIATELY STOPPING LIMBREL, PLEASE SCHEDULE AN APPOINTMENT WITH YOUR PHYSICIAN TO EVALUATE YOUR HEALTH AND DISCUSS ALTERNATIVE THERAPIES.
Arthritis and Rheumatism Associates, P.C. strives to provide the most comprehensive, safe, and effective care for our patients. We understand that all medications and supplements have risks and potential side effects, so it is our general practice to routinely monitor patients’ medications. As of December 21, 2017, Primus Pharmaceuticals took action to remove Limbrel from the market.
For more information, please visit www.fda.gov here for Limbrel message. Please do not hesitate to call our office with any questions.
The Physicians of Arthritis and Rheumatism Associates, P.C.